Manuel Gutiérrez de Ravé: Promotion to Real-World Evidence Scientist at Terumo Blood and Cell Technologies
Manuel Gutiérrez de Ravé, Real-World Evidence (RWE) Scientist at Terumo Blood and Cell Technologies, shared a post on LinkedIn:
“My pleasure to share that I’ve been promoted to Real-World Evidence (RWE) Scientist at Terumo Blood and Cell Technologies.
l’Il generate RWE as a data-driven decision model to advance blood banking in productivity, quality, and safety by supporting post-market surveillance studies with customers worldwide.
Cross-functionally, I’ll continue collaborating with clinicians, industry leaders, academia, and donor associations to improve transfusion medicine and regulatory frameworks — ultimately strengthening healthcare systems.
Additionally, I’ll provide scientific education to internal and external stakeholders. In today’s digital world, flooded with fake news and unverified information, education stands as a vital pillar of society, now more than ever.
Finally, it’s a privilege to learn from exceptional experts and caring individuals. My deepest gratitude goes to my mentors: Marcia Cardoso and Anna Razatos – I feel profoundly lucky that our paths have crossed.”
Stay updated with Hemostasis Today.
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session
-
Aug 30, 2026, 17:02David McGlasson: A 2020 Article Reaches 8,000 Reads
-
Aug 30, 2026, 16:18Tushar Namdeo: Platelets in Different Diseases
-
Aug 30, 2026, 16:16Fatima Zafar: Anaemia – Why This “Common” Condition Should Never Be Ignored
-
Aug 30, 2026, 16:13Umeshkumar C.: Evaluating Scoring Systems and Biomarkers for DIC in Critically Ill Patients